Dear Sir/Madam, With reference to the captioned subject please find the attached report on investor complaints for the quarter ended 30th September, 2025. You are requested to kindly ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has filed a quarterly investor complaints report with BSE and MSEI as required under SEBI's Listing Regulations. The report, covering the quarter ended 30 September 2025, shows zero complaints pending at the start of the quarter, zero received during the quarter, zero disposed of, and zero unresolved at the end. The filing was submitted by the company's Registrar and Share Transfer Agent, Purva Sharegistry (India) Pvt Ltd, on 17 October 2025. This is a routine regulatory compliance filing and indicates no shareholder grievances were raised during the period.
This is a routine compliance disclosure with no material impact on shareholders or the stock. Zero complaints suggests smooth shareholder servicing and no governance red flags from investor grievances during the quarter.